Helomics

Helomics is dedicated to improving patient outcomes by utilizing a proprietary set of laboratory platforms and our Product Science as a Service commercialization model to allow physicians to characterize malignant tumors. Our novel molecular and cellular markers and bioinformatics services are designed to support treatment decisions by providing vital information based on the specific biological processes of each individual's cancer. Helomics' ongoing array of multiple products and technologies provide unique clinical value through a Comprehensive Tumor Profile, which includes: ChemoFx®, BioSpeciFx®, GeneFx Colon and Lung. This approach to precision medicine combines tumor of origin information, genomic expression and molecular information specific and clinically relevant to a patient’s cancer, answering a broad range of clinical questions that physicians encounter every day while managing their patient’s care throughout the Continuum of Cancer. Our philosophy: Patients first, therapies second. Personalized healthcare should be comprehensive, precise, predictive, but most importantly, personal. At Helomics™ we believe that each patient is unique, and their cancer treatment should be too. Our in-depth approach to characterizing patients' live and archived cancer cells allows us to create personal tumor profiles that help physicians to individualize treatment options for their patients.